US6289881079 - ADR
/PRNewswire/ -- Mynd.ai, Inc. ("Mynd" or the "Company") (NYSE: MYND), is pleased to announce the successful completion of the merger transaction ("Merger...
Gainers: Soliton (NASDAQ:SOLY) +124%. Exela Technologies (NASDAQ:XELA) +33%. Flexible Solutions International (NYSEMKT:FSI) +24%. IMAC Holdings (NASDAQ:IMAC) +20%. Biocept (NASDAQ:BIOC) +21%. Anaplan
Gainers: Soliton (NASDAQ:SOLY) +80%. Biocept (NASDAQ:BIOC) +25%. Armata Pharmaceuticals (NYSEMKT:ARMP) +16%. OncoSec Medical (NASDAQ:ONCS) +15%. MYnd Analytics (NASDAQ:MYND) +10%.Losers: Kezar Life Sc
In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on MYnd Analytics Inc (MYND), with a price target of $4. The
Gainers: Netshoes (Cayman) Limited (NYSE:NETS) +42%. MYnd Analytics (NASDAQ:MYND) +16%. S&W Seed Company (NASDAQ:SANW) +16%. Universal Corporation (NYSE:UVV) +15%. L Brands (NYSE:LB) +12%. Realm T
Gainers: MYnd Analytics (NASDAQ:MYND) +23%. Tonix Pharmaceuticals (NASDAQ:TNXP) +15%. Ekso Bionics Holdings (NASDAQ:EKSO) +9%. Evofem Biosciences (NASDAQ:EVFM) +6%. Enochian Biosciences (NASDAQ:ENOB)